Skip to main content
SpringerLink
Log in

Gender and Outcome in Schizophrenia

  • Chapter
  • First Online:
Schizophrenia Treatment Outcomes

Abstract

Sex and gender play a role in outcome of mental illness because men and women differ genetically; the shape and function of their brains differ, and they are exposed to sometimes different stressors. Their contrasting paths in life are determined by local tradition, and their opportunities, including easy access to health care, differ in many regions around the world. Their response to treatment may also be sexually dimorphic, depending on the treatments offered. Conclusions about gender and outcome depend on which component of outcome is being studied, at what age, and where. This chapter explores these issues in the context of schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schmiedebach HP, Beddies T, Schulz J, Priebe S. Housing and work as criteria of the “social integration” of the mentally ill–development in Germany between 1900 and 2000. Psychiatr Prax. 2002;29(6):285–94. [Article in German].

    Article  PubMed  Google Scholar 

  2. Ross DR, Lewin R, Gold K, Ghuman HS, Rosenblum B, Salzberg S, et al. The psychiatric uses of cold wet sheet packs. Am J Psychiatry. 1988;145(2):242–5.

    Article  PubMed  Google Scholar 

  3. Whitrow M. Wagner-Jauregg and fever therapy. Med Hist. 1990;34(3):294–310.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kalinowsky LB. History of convulsive therapy. Ann N Y Acad Sci. 1986;462:1–4.

    Article  PubMed  Google Scholar 

  5. Jasper HH. A historical perspective. The rise and fall of prefrontal lobotomy. Adv Neurol. 1995;66:97–114.

    PubMed  Google Scholar 

  6. Freeman W. Frontal lobotomy 1936-1956: a follow-up study of 3000 patients from one to twenty years. Am J Psychiatry. 1957;113(10):877–86.

    Article  PubMed  Google Scholar 

  7. Wing JK. Five-year outcome in early schizophrenia. Proc Royal Soc Med. 1966;59(1):17–8.

    Article  Google Scholar 

  8. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10(3):799–812.

    Article  Google Scholar 

  9. Grossman LS, Harrow M, Rosen C, Faull R, Strauss GP. Sex differences in schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis and recovery. Compr Psychiatry. 2008;49(6):523–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Grob GN. From asylum to community: mental health policy in modern America. Princeton: Princeton University Press; 2014.

    Book  Google Scholar 

  11. Folsom D, Jeste DV. Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatr Scand. 2002;105(6):404–13.

    Article  PubMed  Google Scholar 

  12. Folsom DP, Hawthorne W, Lindamer L, Gilmer T, Bailey A, Golshan S, et al. Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psych. 2005;162(2):370–6.

    Article  Google Scholar 

  13. Ran MS, Mao WJ, Chan CL, Chen EY, Conwell Y. Gender differences in outcomes in people with schizophrenia in rural China: 14-year follow-up study. Br J Psychiatry. 2015;206(4):283–8.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Heinze HJ, Toro PA, Urberg KA. Antisocial behavior and affiliation with deviant peers. J Clin Child Adolesc Psychol. 2004;33(2):336–46.

    Article  PubMed  Google Scholar 

  15. Caton CLM, Shrout PE, Dominguez B, Eagle P, Opler LA, Cournos F. Risk factors for homelessness among women with schizophrenia. Am J Public Health. 1995;85(8):1153–6.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Thorup A, Albert N, Bertelsen M, Petersen L, Jeppesen P, Le Quack P, et al. Gender differences in first-episode psychosis at 5-year follow-up--two different courses of disease? Results from the OPUS study at 5-year follow-up. Eur Psychiatry. 2014;29(1):44–51.

    Article  PubMed  Google Scholar 

  17. Greve J, Herrup Nielsen L. Useful beautiful minds—an analysis of the relationship between schizophrenia and employment. J Health Econ. 2013;32(6):1066–76.

    Article  PubMed  Google Scholar 

  18. Bouwmans C, de Sonneville C, Mulder CL, Hakkaart-van Roijen L. Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2125–42.

    PubMed  PubMed Central  Google Scholar 

  19. Chatterji P, Alegria M, Takeuchi D. Psychiatric disorders and labor market outcomes: evidence from the National Comorbidity Survey-Replication. J Health Econ. 2011;30(5):858–68.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Drake RE, Bond GR, Thornicroft G, Knapp M, Goldman HH. Mental health disability: an international perspective. J Disab Policy Stud. 2012;23(2):110–20.

    Article  Google Scholar 

  21. Ran MS, Wong YI, Yang SY, Ho PS, Mao WJ, Li J, et al. Marriage and outcomes of people with schizophrenia in rural China: 14-year follow-up study. Schizophr Res. 2017;182:49–54. https://doi.org/10.1016/j.schres.2016.10.034.

    Article  PubMed  Google Scholar 

  22. Hopper K, Wanderling J, Narayanan P. To have and to hold: a cross-cultural inquiry into marital prospects after psychosis. Glob Public Health. 2007;2(3):257–80.

    Article  PubMed  Google Scholar 

  23. Reupert A, Maybery D, Cox M, Scott Stokes E. Place of family in recovery models for those with a mental illness. Int J Ment Health Nurs. 2015;24(6):495–506.

    Article  PubMed  Google Scholar 

  24. Yu MY, Shim W. Couples with schizophrenia “becoming like others” in South Korea: marriage as part of a recovery process. Fam Proc. 2009;48(3):429–40.

    Article  Google Scholar 

  25. Khalifeh H, Moran P, Borschmann R, Dean K, Hart C, Hogg J, et al. Domestic and sexual violence against patients with severe mental illness. Psychol Med. 2015;45(4):875–86.

    Article  PubMed  Google Scholar 

  26. Jonas S, Khalifeh H, Bebbington PE, McManus S, Brugha T, Meltzer H, et al. Gender differences in intimate partner violence and psychiatric disorders in England: results from the 2007 adult psychiatric morbidity survey. Epidemiol Psychiatr Sci. 2014;23(2):189–99.

    Article  PubMed  Google Scholar 

  27. Trevillion K, Oram S, Feder G, Howard LM. Experiences of domestic violence and mental disorders: a systematic review and meta-analysis. PLoS One. 2012;7(12):e51740.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Frayne J, Brooks J, Nguyen TN, Allen S, Maclean M, Fisher J. Characteristics of men accompanying their partners to a specialist antenatal clinic for women with severe mental illness. Asian J Psychiatry. 2014;7(1):46–51.

    Article  Google Scholar 

  29. Seeman MV. Bad, burdened or ill? Characterizing the spouses of women with schizophrenia. Int J Soc Psychiatry. 2013;59(8):805–10.

    Article  PubMed  Google Scholar 

  30. Ranning A, Laursen TM, Thorup A, Hjorthøj C, Nordentoft M. Children of parents with serious mental illness: with whom do they grow up? A prospective, population-based study. J Am Acad Child Adolesc Psychiatry. 2016;55(11):953–61.

    Article  PubMed  Google Scholar 

  31. Fazel S, Wolf A, Palm C, Lichtenstein P. Violent crime, suicide, and premature mortality in patients with schizophrenia and related disorders: a 38-year total population study in Sweden. Lancet Psychiatry. 2014;1(1):44–54.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Schrank B, Rumpold T, Gmeiner A, Priebe S, Aigner M. Parenthood among patients with psychotic disorders: gender differences in a non-selective clinical sample. Psychiatry Res. 2016;246:474–9.

    Article  PubMed  Google Scholar 

  33. Bhatia T, Franzos MA, Wood JA, Nimgaonkar VL, Deshpande SN. Gender and procreation among patients with schizophrenia. Schizophr Res. 2004;68(2–3):387–94.

    Article  PubMed  Google Scholar 

  34. Ranning A, Laursen TM, Thorup A, Hjorthøj C, Nordentoft M. Serious mental illness and disrupted caregiving for children: a nationwide, register-based cohort study. J Clin Psychiatry. 2015;76(8):1006–14.

    Article  Google Scholar 

  35. Seeman MV. Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr Res Treat. 2012;2012:796763.

    Google Scholar 

  36. Seeman MV. Parenting issues in mothers with schizophrenia. Curr Womens Health Rev. 2010;6(1):51–7.

    Article  Google Scholar 

  37. Drake RE, McHugo GJ, Xie H, Fox M, Packard J, Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophr Bull. 2006;32(3):464–73.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Drake RE, Luciano AE, Mueser KT, Covell NH, Essock SM, Xie H, et al. Longitudinal course of clients with co-occurring schizophrenia-spectrum and substance use disorders in urban mental health centers: a 7-year prospective study. Schizophr Bull. 2016;42(1):202–11.

    PubMed  Google Scholar 

  39. Potvin S, Joyal CC, Pelletier J, Stip E. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr Res. 2008;100(1-3):242–51.

    Article  PubMed  Google Scholar 

  40. Wojtalik JA, Barch DM. An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia. Front Psych. 2014;5:1.

    Google Scholar 

  41. Wong QJ, Miller M. Broad spectrum psychiatric comorbidity is associated with better executive functioning in an inpatient sample of individuals with schizophrenia. Compr Psychiatry. 2015;60:47–52.

    Article  PubMed  Google Scholar 

  42. Potvin S, Stavro K, Pelletier J. Paradoxical cognitive capacities in dual diagnosis schizophrenia: the quest for explanatory factors. J Dual Diagn. 2012;8(1):35–47. https://doi.org/10.1080/15504263.2012.648549.

    Article  Google Scholar 

  43. Buccelli C, Della Casa E, Paternoster M, Niola M, Pieri M. Gender differences in drug abuse in the forensic toxicological approach. Forensic Sci Int. 2016;265:89–95.

    Article  PubMed  Google Scholar 

  44. Randall CL, Roberts JS, Del Boca FK, Carroll KM, Connors GJ, Mattson ME. Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol. 1999;60(2):252–60.

    Article  PubMed  Google Scholar 

  45. Elbogen EB, Johnson SC. The intricate link between violence and mental disorder: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2009;66(2):152–61.

    Article  PubMed  Google Scholar 

  46. Fazel S, Gulati G, Linsell L, Geddes JR, Grann M. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009;6:e1000120.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Wynn R. Medicate, restrain or seclude? Strategies for dealing with violent and threatening behaviour in a Norwegian university psychiatric hospital. Scand J Caring Sci. 2002;16(3):287–91.

    Article  PubMed  Google Scholar 

  48. Beck NC, Durrett C, Stinson J, Coleman J, Stuve P, Menditto A. Trajectories of seclusion and restraint at a state psychiatric hospital. Psychiatr Serv. 2008;59(9):1027–32.

    Article  PubMed  Google Scholar 

  49. Nawka A, Kalisova L, Raboch J, Giacco D, Cihal L, Onchev G, et al. Gender differences in coerced patients with schizophrenia. BMC Psychiatry. 2013;13:257.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Keski-Valkama A, Sailas E, Eronen M, Koivisto AM, Lönnqvist J, Kaltiala-Heino R. Who are the restrained and secluded patients: a 15-year nationwide study. Soc Psychiatry Psychiatr Epidemiol. 2010;45(11):1087–93.

    Article  PubMed  Google Scholar 

  51. Smith GM, Davis RH, Bixler EO, Lin HM, Altenor A, Altenor RJ, et al. Pennsylvania state hospital system’s seclusion and restraint reduction program. Psychiatr Serv. 2005;56(9):1115–22.

    Article  PubMed  Google Scholar 

  52. Popovic D, Benabarre A, Crespo JM, Goikolea JM, González-Pinto A, Gutiérrez-Rojas L, et al. Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand. 2014;130(6):418–26.

    Article  PubMed  Google Scholar 

  53. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005;187(1):9–20.

    Article  Google Scholar 

  54. Lester D. Sex differences in completed suicide by schizophrenic patients: a meta-analysis. Suicide Life Threat Behav. 2006;36(1):50–6.

    Article  PubMed  Google Scholar 

  55. Kiviniemi M. Mortality, disability, psychiatric treatment and medication in first-onset schizophrenia in Finland: the register linkage study. Acta Univ Oulu. 2014; D 1267. Available at: http://jultika.oulu.fi/files/isbn9789526206325.pdf.

  56. Austad G, Joa I, Johannessen JO, Larsen TK. Gender differences in suicidal behaviour in patients with first-episode psychosis. Early Interv Psychiatry. 2015;9(4):300–17.

    Article  PubMed  Google Scholar 

  57. Mancuso SG, Morgan VA, Mitchell PB, Berk M, Young A, Castle DJ. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the second Australian national psychosis survey. J Affect Disord. 2015;172:30–7.

    Article  PubMed  Google Scholar 

  58. Large M, Smith G, Sharma S, Nielssen O, Singh SP. Systematic review and meta-analysis of the clinical factors associated with the suicide of psychiatric in-patients. Acta Psychiatr Scand. 2011;124(1):18–29.

    Article  PubMed  Google Scholar 

  59. Hiroeh U, Appleby L, Mortensen PB, Dunn G. Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study. Lancet. 2001;358(9299):2110–2.

    Article  PubMed  Google Scholar 

  60. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.

    Article  Google Scholar 

  61. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115–21.

    Article  PubMed  Google Scholar 

  62. Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211–8.

    Article  PubMed  Google Scholar 

  63. Bai YM, Su TP, Chen MH, Chen TJ, Chang WH. Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study. J Affect Dis. 2013;150(1):57–62.

    Article  PubMed  Google Scholar 

  64. Crump C, Sunquist K, Winkleby MA, Sundquist J. Mental disorders and risk of accidental death. Br J Psychiatry. 2013;203(3):297–302.

    Article  PubMed  Google Scholar 

  65. Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiat. 2015;72(12):1172–81.

    Article  Google Scholar 

  66. Yuen K, Harrigan SM, Mackinnon AJ, Harris MG, Yuen HP, Henry LP, et al. Long-term follow-up of all-cause and unnatural death in young people with first-episode psychosis. Schizophr Res. 2014;159(1):70–5.

    Article  PubMed  Google Scholar 

  67. Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011;131(1-3):101–4.

    Article  PubMed  Google Scholar 

  68. Capasso RM, Lineberry TW, Bostwick JM, Decker PA, St. Sauver J. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950–2005. Schiz Res. 2008;98(1-3):287–94.

    Article  Google Scholar 

  69. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64(10):1123–31.

    Article  PubMed  Google Scholar 

  70. Zhou J, Xiang YT, Li Q, Zhu X, Li W, Ungvari GS, et al. Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia. Psychiatry Res. 2016;245:276–81.

    Article  PubMed  Google Scholar 

  71. Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004;44:499–523.

    Article  PubMed  Google Scholar 

  72. Mauri MC, Volonteri LS, Colasanti A, Fiorentini A, De Gaspari IF, Bareggi SR. Clinical pharmacokinetics of atypical antipsychotics. A critical review of the relationship between plasma. Concentrations and clinical response. Clin Pharmacokinet. 2007;46(5):359–88.

    Article  PubMed  Google Scholar 

  73. Spina E, de Leon J. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2014;10(5):721–46.

    Article  PubMed  Google Scholar 

  74. Usall J, Suarez D, Haro JM, SOHO Study Group. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res. 2007;153(3):225–31.

    Article  PubMed  Google Scholar 

  75. Wils RS, Gotfredsen DR, Hjorthøj C, Austin SF, Albert N, Secher RG, et al. Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis. Schizophr Res. 2017;182:42–8.

    Article  PubMed  Google Scholar 

  76. Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull. 2009;35(5):937–48.

    Article  PubMed  Google Scholar 

  77. Young SL, Taylor M, Lawrie SM. “First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol. 2015;29(4):353–62.

    Article  PubMed  Google Scholar 

  78. D’Incau P, Lapeyre-Mestre M, Carvajal A, Donati M, Salado I, Rodriguez L, et al. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain. Fundam Clin Pharmacol. 2014;28(3):342–8.

    Article  PubMed  Google Scholar 

  79. Holm L, Ekman E, Jorsäter Blomgren K. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2017;26(3):335–43.

    Article  PubMed  Google Scholar 

  80. Barbui C, Nosè M, Bindman J, Schene A, Becker T, Mazzi MA, et al. Sex differences in the subjective tolerability of antipsychotic drugs. J Clin Psychopharmacol. 2005;25(6):521–6.

    Article  PubMed  Google Scholar 

  81. Seeman MV. Antipsychotics and physical attractiveness. Clin Schizophr Relat Psychoses. 2011;5(3):142–6.

    Article  PubMed  Google Scholar 

  82. Haack S, Seeringer A, Thurmann PA, Becker T, Kirchheiner J. Sex-specific differences in side effects of psychotropic drugs: genes or gender? Pharmacogenomics. 2009;10(9):1511–26.

    Article  PubMed  Google Scholar 

  83. Wu Chou AI, Wang YC, Lin CL, Kao CH. Female schizophrenia patients and risk of breast cancer: a population-based cohort study. Schizophr Res. 2017. https://doi.org/10.1016/j.schres.2017.01.019.

    Article  PubMed  Google Scholar 

  84. Seeman MV. Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatr Scand. 2013;127(1):12–22.

    Article  PubMed  Google Scholar 

  85. Seeman MV. Menstrual exacerbation of schizophrenia symptoms. Acta Psychiatr Scand. 2012;125(5):363–71.

    Article  PubMed  Google Scholar 

  86. Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol. 2015;125(5):1224–35.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol. 2015;116(4):315–20.

    Article  PubMed  Google Scholar 

  88. Larsen ER, Damkier P, Pedersen LH, Fenger-Gron J, Mikkelsen RL, Nielsen RE, et al. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand. 2015;132(S445):1–28.

    Article  Google Scholar 

  89. Kulkarni J, Storch A, Baraniuk A, Gilbert H, Gavrilidis E, Worsley R. Antipsychotic use in pregnancy. Expert Opin Pharmacother. 2015;16(9):1335–45.

    Article  PubMed  Google Scholar 

  90. Rabinowitz J, Werbeloff N, Caers I, Mandel FS, Stauffer V, Ménard F, et al. Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials. J Clin Psychiatry. 2014;75:e308–16.

    Article  PubMed  Google Scholar 

  91. Chang CK, Hayes RD, Perera G, Broadbent MT, Fernandes AC, Lee WE, et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One. 2011;6(5):e19590.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Usall J, Haro JM, Ochoa S, Márquez M, Araya S, the NEDES group. Influence of gender on social outcome in schizophrenia. Acta Psychiatr Scand. 2002;106(5):337–42.

    Article  PubMed  Google Scholar 

  93. Ritsher JE, Coursey RD, Farrell EW. A survey on issues in the lives of women with severe mental illness. Psych Serv. 1997;48(10):1273–82.

    Article  Google Scholar 

  94. Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment. 2012;2012:916198.

    PubMed  PubMed Central  Google Scholar 

  95. Remberk B, Bażyńska AK, Krempa-Kowalewska A, Rybakowski F. Adolescent insanity revisited: course and outcome in early-onset schizophrenia spectrum psychoses in an 8-year follow-up study. Compr Psychiatry. 2014;55(5):1174–81.

    Article  PubMed  Google Scholar 

  96. Juola P, Miettunen J, Veijola J, Isohanni M, Jääskeläinen E. Predictors of short–and long-term clinical outcome in schizophrenic psychosis–the northern Finland 1966 birth cohort study. Eur Psychiatry. 2013;28(5):263–8.

    Article  PubMed  Google Scholar 

  97. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39(6):1296–306.

    Article  PubMed  Google Scholar 

  98. Carpiniello B, Pinna F, Tusconi M, Zaccheddu E, Fatteri F. Gender differences in remission and recovery of schizophrenic and schizoaffective patients. Preliminary results of a prospective court study. Schizophr Res Treatment. 2012;2012:576369.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Shibre T, Medhin G, Alem A, Kebede D, Teferra S, Jacobsson L, et al. Long-term clinical course and outcome of schizophrenia in rural Ethiopia: 10-year follow-up of a population-based cohort. Schizophr Res. 2015;161(2-3):414–20.

    Article  PubMed  Google Scholar 

  100. Carbon M. Clinical predictors of therapeutic response to antipsychotics in schizophrenia. Dialogues Clin Neurosci. 2014;16(4):505–24.

    PubMed  PubMed Central  Google Scholar 

  101. Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM. Sex differences in the course of schizophrenia across diverse regions of the world. Neuropsychiatr Dis Treat. 2016;12:2927–39.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Science, Department of Psychiatry, Toronto, ON, Canada

    Mary V. Seeman

Authors
  1. Mary V. Seeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary V. Seeman .

Editor information

Editors and Affiliations

  1. Lawson Health Research Institute, Western University Lawson Health Research Institute, London, ON, Canada

    Amresh Shrivastava

  2. Lokmanya Tilak Municipal Medical College, De Sousa Foundation, Mumbai, India

    Avinash De Sousa

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Seeman, M.V. (2020). Gender and Outcome in Schizophrenia. In: Shrivastava, A., De Sousa, A. (eds) Schizophrenia Treatment Outcomes. Springer, Cham. https://doi.org/10.1007/978-3-030-19847-3_3

Download citation

Publish with us

Policies and ethics

Search

Navigation